Top Markets
Coin of the day
Angion Biomedica Corp. Angion Biomedica Corp.

Angion Biomedica Corp.

ANGN
Clasificación en acciones #27863
Angion Biomedica Corp. operates as a biopharmaceutical enterprise,... Angion Biomedica Corp. operates as a biopharmaceutical enterprise, concentrating its efforts on the identification, advancement, and market introduction of small molecule treatments for severe organ damage and scarring conditions. Its primary investigational compound, ANG-3070, is an orally administered tyrosine kinase receptor inhibitor currently being developed to address fibrotic ailments, particularly those impacting the kidneys and lungs. The company's product pipeline also features ANG-3777, a hepatocyte growth factor mimetic engineered to treat acute organ injuries like delayed graft function, in addition to initiatives for ROCK2 inhibitors targeting fibrotic diseases and a CYP11B2 inhibitor program. Established in 1998, Angion Biomedica Corp. maintains its headquarters in Uniondale, New York.
Precio por acción
$1.00
Última sincronización: 2023-06-01
Capitalización bursátil
$30.11M
Cambio (1 día)
2.04%
Cambio (1 año)
0.00%
País
US
Comercio Angion Biomedica Corp. (ANGN)

Categoría

Historial de desdoblamientos de acciones de Angion Biomedica Corp. (ANGN)
La acción Angion Biomedica Corp. (símbolo: ANGN) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 20, 2026.
Una acción ANGN comprada antes de Aug 20, 2026 equivaldría hoy a 0 acciones ANGN.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH